Edinburg, the county seat of Hidalgo County, Texas, is one of the fastest‑growing cities in South Texas, with an estimated population exceeding 108,000 residents and rapid expansion in recent years. This vibrant growth brings opportunity, but it also highlights a major public health challenge: …
Why Are Obesity Rates So High in Edinburg, Hidalgo County, Texas? Causes, Statistics, and Proven Solutions
Obesity has become one of the most serious public health challenges in Edinburg and the broader Hidalgo County region of South Texas. Over the past two decades, this rapidly growing area has consistently reported obesity rates far above both state and national averages. Recent community health …
How to Manage and Control Obesity in McAllen Texas: Proven Strategies, Statistics, and Local Tips
McAllen, Texas, is a vibrant city full of culture, great food, and community spirit—but it is also facing one of the nation’s most pressing health issues: obesity. Currently, over 45% of adults in McAllen are obese, and nearly 30% of children are overweight or obese, making it one of the …
Why Obesity Rates Are So High in McAllen Texas (Hidalgo County): Statistics, Causes, and Future Predictions for 2030
McAllen, located in Hidalgo County in South Texas, has consistently ranked among the most overweight and obese cities in the United States. Recent health assessments indicate that approximately 45% of McAllen adults are obese and an additional 31% are overweight, meaning nearly three out of every …
New Research Study Links Obesity in the U.S. to Rising Cardiovascular Disease and Heart Failure Rates
Obesity has long been recognized as a public health crisis in the U.S., but recent research is highlighting an even more alarming trend: the connection between rising obesity rates and increased cardiovascular disease (CVD), including heart failure. According to a new analysis, obesity-related …
Innovative Drug Combines GLP-1 and NMDA Receptor Targeting for Obesity Treatment
The EASD 2024 conference showcased an innovative study titled "GLP-1 Directed NMDA Receptor Antagonism for Obesity Treatment”. This research has revealed a novel approach to combating obesity by using a “Trojan horse” strategy that combines a small molecule with a gut-hormone-mimicking …